Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Secora Michael
Relationship:   Chief Financial Officer
City:   Salt Lake City
State:   UT
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   1,231,055    

Indirect Shares

   0      
Direct Value   $10,636,315    

Indirect Value

   $0      
Total Shares   1,231,055      
Total Value   $10,636,315      


Recursion Pharmaceuticals, Inc. $10,636,315 Recursion Pharmaceuticals, Inc. $10,636,315
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Recursion Pharmaceuticals, Inc. RXRX Chief Financial Officer 2024-04-17 1,231,055 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-04-17 4 AS $7.58 $175,349 D/D (23,124) 1,231,055 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-04-17 4 OE $2.22 $83,250 D/D 37,500 1,254,179 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-04-16 4 AS $7.67 $191,658 D/D (25,000) 1,216,679 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-04-16 4 OE $2.22 $83,250 D/D 37,500 1,241,679 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-03-13 4 AS $11.03 $275,815 D/D (25,000) 1,204,179 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-03-13 4 OE $2.22 $83,250 D/D 37,500 1,229,179 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-03-12 4 AS $10.46 $261,375 D/D (25,000) 1,191,679 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-03-12 4 OE $2.22 $83,250 D/D 37,500 1,216,679 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-15 4 D $12.43 $89,148 D/D (7,172) 1,179,179 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-14 4 AS $10.43 $261,425 D/D (25,000) 1,186,351 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-14 4 OE $2.22 $83,250 D/D 37,500 1,211,351 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-13 4 AS $9.86 $246,560 D/D (25,000) 1,173,851 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-13 4 OE $2.22 $83,250 D/D 37,500 1,198,851 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-09 4 D $10.09 $25,346 D/D (2,512) 1,161,351 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 182,849 1,163,863 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-01-17 4 OE $2.22 $83,250 D/D 37,500 1,006,014 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-01-17 4 AS $10.25 $256,348 D/D (25,000) 981,014 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-01-16 4 AS $10.45 $261,160 D/D (25,000) 968,514 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2024-01-16 4 OE $2.22 $83,250 D/D 37,500 993,514 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2023-12-13 4 AS $7.59 $189,770 D/D (25,000) 956,014 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2023-12-13 4 OE $2.22 $83,250 D/D 37,500 981,014 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2023-12-12 4 AS $7.39 $184,868 D/D (25,000) 943,514 0 %
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2023-12-12 4 OE $2.22 $83,250 D/D 37,500 968,514 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2023-11-15 4 OE $2.22 $83,250 D/D 37,500 963,186 0 -
RXRX Recursion Pharmaceuticals... Chief Financial Officer   •       –      –    2023-11-15 4 D $7.18 $51,495 D/D (7,172) 931,014 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us